Influence in the outcome of neuropathic pediatric patients after early treatment

Area of Science:

• Pediatric Urology
• Nephrology
• Neurology

Background:

• Neuropathic bladder (NB) is primarily managed with clean intermittent catheterization (CIC) and anticholinergic drugs.
• Optimal timing for initiating conservative treatment in pediatric NB patients remains debated.

Purpose of the Study:

• To evaluate the long-term impact of early (within the first year of life) versus later initiation of CIC and anticholinergic treatment on renal and bladder function in pediatric NB patients.
• To test the hypothesis that earlier treatment leads to improved outcomes and reduced surgical intervention.

Main Methods:

• Retrospective analysis of 61 pediatric NB patients (1995-2005).
• Patients were divided into two groups: early treatment (Group 1, first year of life) and later treatment (Group 2, 1-5 years old).
• Data collected included treatment initiation dates, VUR, UHN, renal function, UTIs, renal scars, bladder behavior, and surgical outcomes.

Main Results:

• Group 1 showed a lower incidence of low-compliant bladders and required significantly less bladder augmentation (2 vs. 12 patients).
• While initially more frequent in Group 2, vesico-ureteral reflux (VUR) and overactive bladders showed less favorable changes in Group 2.
• No significant renal insufficiency was noted in Group 1, with only 2 patients in Group 2 experiencing slight renal insufficiency.

Conclusions:

• Early initiation of conservative treatment (CIC and anticholinergics) within the first year of life is associated with superior long-term outcomes in pediatric neuropathic bladder.
• Early treatment correlates with fewer urinary tract infections (UTIs), reduced renal scarring, and a decreased need for surgical interventions like bladder augmentation.
• Even in cases with initial low-compliant bladders, early conservative management offers better functional preservation and reduces the necessity for invasive procedures.